AG百家乐大转轮-AG百家乐导航_怎么看百家乐走势_全讯网官网 (中国)·官方网站

Research News

Bronchial Thermoplasty was carried out successfully in the respiratory department of The Sixth Affiliated Hospital

Source: The Sixth Affiliated Hospital
Written by: Jian Wenyang, Wang Jun
Edited by: Wang Dongmei

Professor Gerard Cox from McMaster University in Canada visited the respiratory department of The Sixth Affiliated Hospital of SYSU recently. Professor Chen Zhengxian, the Chief Physician of the department, and his team gave reception to Professor Gerard Cox. They discussed an innovative technology in treatment of severe asthma, Bronchial Thermoplasty (BT), and examined patients who were candidated for BT. Professor Cox also gave a lecture about the operational essentials, safety and clinical outcome of Bronchial Thermoplasty. The event laid a foundation for the promotion of Bronchial Thermoplasty in China.

 
Professor Gerard Cox (first from left) from McMaster University discussing Bronchial Thermoplasty with the team
led by Professor Chen Zhengxian (first from right) from the respiratory department of The Sixth Affiliated Hospital
 
Professor Gerard Cox, who is famous for the treatment of asthma and Bronchial Thermoplasty in Canada, offered some practical experience about screening patients, operating process and skills, and patient management of Bronchial Thermoplasty. This was really good news for patients with severe asthma.

According to Professor Chen Zhengxian, Bronchial Thermoplasty is an effective treatment for severe, uncontrolled asthma patients who were poor responding to standard drug treatment (inhaled corticosteroids and long-acting b2-agonists). This operation delivers therapeutic radiofrequency energy provided by the Alair? System to the airway wall, via a catheter inserted into the bronchi through a flexible bronchoscope, thus reducing the amount of smooth muscle cell in the airway wall and reducing the ability of the smooth muscle to bronchoconstrict. This treatment could reduce asthma symptoms and exacerbations, and improved quality of life.

The treatment has been shown to be uncomplicated, safe and effective over 10 years abroad. It was approved by the US Food and Drug Administration (FDA) and Passed Premarket Approval (PMA) process. Patients with severe persistent asthma, 18 years and older, who experience asthma symptoms despite taking high dose Corticosteroids (ICS) and Long-acting β-agonists (LABA), and can tolerant Bronchial endoscopy are indicated to Bronchial Thermoplasty. Even patients with severe airflow obstruction could be improved by this treatment.

Professor Chen Zhenxian is a well known Interventional Pulmonology specialist and his team is developing this promising technology. More and more patients will benefit from this therapy.

百家乐官网类游戏平台| 百家乐博赌场娱乐网规则| e世博百家乐官网娱乐场| 马牌| 百家乐官网评测| 路单百家乐的玩法技巧和规则| 东方太阳城| 百家乐官网的玩法技巧和规则 | 钱大发888游戏下载| 尊龙百家乐官网赌场娱乐网规则 | 百家乐官网猜大小规则| 百家乐官网永利赌场娱乐网规则| 百家乐论坛bocaila| 牌9娱乐| 誉博百家乐官网开户导航| 百家乐最低下注| 战神国际娱乐平| 圣保罗百家乐官网的玩法技巧和规则| 百家乐倍投工具| 千亿百家乐官网的玩法技巧和规则| 百家乐桌| 百家乐官网咋个玩的| 皇马百家乐的玩法技巧和规则| 澳门百家乐官网视频| 百家乐打印机分析| 马牌百家乐官网娱乐城| 百家乐制胜软件| 百家乐官网代理在线游戏可信吗网上哪家平台信誉好安全 | 百家乐群柏拉图软件| 百家乐官网高额投注| 大发888优惠代码| 网络百家乐程序| 新濠百家乐官网的玩法技巧和规则 | 赌博百家乐官网赢不了| 大发888游戏登陆| 传奇百家乐官网的玩法技巧和规则| 皇冠网上开户| Bet百家乐娱乐城| 百家乐官网国际赌场娱乐网规则| 巴林右旗| 足球竞猜规则|